| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 163,200 | 158,939 | 157,690 | 189,956 | | Cost of Revenue | 48,426 | 48,876 | 46,447 | 134,873 | | | Gross Profit | 114,774 | 110,063 | 111,243 | 55,083 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,661 | 23,199 | 21,853 | (54,127) | | Non Recurring | 168,346 | 169 | 2,461 | 117,044 | | Others | 37,726 | 36,058 | 36,293 | 40,463 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (114,959) | 50,637 | 50,636 | (48,297) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,913 | (1,468) | 235 |
-
| | Earnings Before Interest And Taxes | (113,046) | 49,169 | 50,871 | (48,297) | | Interest Expense | 36,407 | 36,473 | 36,233 | 38,404 | | Income Before Tax | (149,453) | 12,696 | 14,638 | (86,701) | | Income Tax Expense | (211) | 198 | 270 | 459 | | Minority Interest | 31,903 |
-
|
-
| (16,299) | | | | Net Income From Continuing Ops | (229,004) | 20,866 | 24,526 | (97,117) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (106,885) | 20,866 | 24,526 | (97,117) | | Preferred Stock And Other Adjustments | 12,812 | (11,958) | (13,027) | (3,659) | | | Net Income Applicable To Common Shares | ($94,073) | $8,908 | $11,499 | ($100,776) |
|
0.51% Nasdaq 
Income Statement
